Access cutting-edge melanoma treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access melanoma specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related melanoma treatment provided free
The trial aims to evaluate the efficacy of Daromun neoadjuvant treatment followed by surgery and adjuvant therapy to improve in a statistically significant manner the recurrence-free survival (RFS) of Stage IIIB/C melanoma patients with respect to the standard of care (surgery and adjuvant therapy).
Sponsor: Philogen S.p.A.
Check if you qualify for this melanoma clinical trial in Chicago, IL
If you're searching for melanoma treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.